Processa Pharmaceuticals

(NASDAQ) PCSA

Current Price$2.13

Market Cap$5.98M

Since IPO (2017)-100%

5 Year-100%

1 Year-54%

1 Month-26%

Processa Pharmaceuticals Financials at a Glance

Market Cap

$5.98M

Revenue (TTM)

$0.00

Net Income (TTM)

-$14.11M

EPS (TTM)

-$10.72

P/E Ratio

-0.20

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$2.13

Volume

205,286.317

Open

$2.10

Price

$2.13

Volume

205,286.317

Open

$2.10

Previous Close

$2.16

Daily Range

$2.07 - $2.38

52-Week Range

$1.76 - $14.24

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$2.13

Volume

205,286.317

Open

$2.10

Previous Close

$2.16

Daily Range

$2.07 - $2.38

52-Week Range

$1.76 - $14.24

Estimated Earnings Date

Aug 6, 2026

PCSA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Processa Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

George K. Ng

Website

www.processapharmaceuticals.com

Headquarters

Hanover, MD 21076, US

PCSA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-281.30%

Return on Capital

-250.81%

Return on Assets

-312.03%

Earnings Yield

-5.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.98M

Shares Outstanding

2.77M

Volume

205.29K

Avg. Volume

67.23K

Financials (TTM)

Gross Profit

-$301.00

Operating Income

-$14.47M

EBITDA

-$14.11M

Operating Cash Flow

-$12.25M

Capital Expenditure

-$2.00

Free Cash Flow

-$12.25M

Cash & ST Invst.

$1.69M

Total Debt

$0.00

Processa Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$301.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.98M

N/A

Market Cap/Employee

$597.89K

N/A

Employees

N/A

Net Income

-$3.38M

-19.1%

EBITDA

-$3.38M

-19.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.69M

-41.6%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-3.12%

N/A

Return on Invested Capital

-5.70%

N/A

Free Cash Flow

-$3.59M

-31.5%

Operating Cash Flow

-$3.59M

-31.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$3.26-6.05%

CTXRCitius Pharmaceuticals, Inc.

CTXRCitius Pharmaceuticals, Inc.$0.57-5.63%

CRISCuris, Inc.

CRISCuris, Inc.$0.35-17.89%

HOTHHoth Therapeutics, Inc.

HOTHHoth Therapeutics, Inc.$0.90-5.23%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

MBRXMoleculin Biotech, Inc.

MBRXMoleculin Biotech, Inc.$2.64-1.86%

ALLRAllarity Therapeutics, Inc.

ALLRAllarity Therapeutics, Inc.$1.31-1.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

NOKNokia

NOKNokia$12.07-0.07%

RIVNRivian Automotive

RIVNRivian Automotive$18.63+0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

Questions About PCSA

What is the current price of Processa Pharmaceuticals?

Processa Pharmaceuticals is trading at $2.16 per share.

What is the 52-week range for Processa Pharmaceuticals?

Over the past 52 weeks, Processa Pharmaceuticals has traded between $1.76 and $14.24.

How much debt does Processa Pharmaceuticals have?

As of the most recent reporting period, Processa Pharmaceuticals reported total debt of $0.00.

How much cash does Processa Pharmaceuticals have on hand?

Processa Pharmaceuticals reported $1.69M in cash and cash equivalents in its most recent financial results.

What is Processa Pharmaceuticals’s dividend yield?

Processa Pharmaceuticals does not currently have a dividend yield.

Processa Pharmaceuticals

Processa Pharmaceuticals Financials at a Glance

PCSA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Processa Pharmaceuticals

PCSA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Processa Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PCSA

What is the current price of Processa Pharmaceuticals?

What is the 52-week range for Processa Pharmaceuticals?

How much debt does Processa Pharmaceuticals have?

How much cash does Processa Pharmaceuticals have on hand?

What is Processa Pharmaceuticals’s dividend yield?

Premium Investing Services